Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Cancer Research

• Publication date

  2011-08-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-11-0812PMID 21810919PMCID PMC3298078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erratum: Autophagy suppresses tumorigenesis through elimination of p62 (Cell (2009) 137 (1062-1075))

  2011cited by this paper
• Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg)

  2010cited by this paper
• Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates

  2009cited by this paper
• Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells

  2009cited by this paper
• Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection

  2009cited by this paper
• Autophagy suppresses tumorigenesis through elimination of p62.

  2009cited by this paper
• A role for NBR1 in autophagosomal degradation of ubiquitinated substrates.

  2009cited by this paper
• Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice

  2009cited by this paper
• Cross-presentation of tumor associated antigens through tumor-derived autophagosomes

  2009influential reference
• Membrane vesicles as conveyors of immune responses

  2009cited by this paper
• Tumour-released exosomes and their implications in cancer immunity

  2008cited by this paper
• The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation.

  2008cited by this paper
• Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes

  2008cited by this paper
• Efficient cross-presentation depends on autophagy in tumor cells.

  2008influential reference
• Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion.

  2007cited by this paper
• p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate Degradation of Ubiquitinated Protein Aggregates by Autophagy*

  2007cited by this paper
• Hydrodynamic gene delivery: its principles and applications.

  2007cited by this paper
• Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway.

  2006cited by this paper
• The DRiP hypothesis decennial: support, controversy, refinement and extension.

  2006influential reference
• p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death

  2005cited by this paper
• Cellular protein is the source of cross-priming antigen in vivo.

  2004cited by this paper
• CD8+ T Cell Cross-Priming via Transfer of Proteasome Substrates

  2004cited by this paper
• Tumour‐induced polarization of tumour vaccine‐draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studies

  2003cited by this paper
• Efficient Chromosomal Mapping of a Methylcholanthrene- Induced Tumor Antigen by CTL Immunoselection1

  2001cited by this paper
• Dissection of Autophagosome Biogenesis into Distinct Nucleation and Expansion Steps

  2000cited by this paper
• Divergent Roles for CD4+ T Cells in the Priming and Effector/Memory Phases of Adoptive Immunotherapy1

  2000cited by this paper
• Intravenous Injection of Naked DNA Encoding Secreted flt3 Ligand Dramatically Increases the Number of Dendritic Cells and Natural Killer Cells in Vivo

  2000cited by this paper
• Shaping the repertoire of cytotoxic T-lymphocyte responses: explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens.

  1999cited by this paper
• Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).

  1999cited by this paper
• The makings of a tumor rejection antigen.

  1999cited by this paper
• Purification and characterization of autophagosomes from rat hepatocytes.

  1998cited by this paper
• Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma.

  1997cited by this paper
• Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

  1996cited by this paper
• Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens

  1996cited by this paper
• Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

  1994cited by this paper
• Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor.

  1993cited by this paper
• Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.

  1991cited by this paper
• In vivo half-life of a protein is a function of its amino-terminal residue.

  1986cited by this paper
• Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis.

  1982cited by this paper
• Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

  1976cited by this paper
• Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene.

  1970cited by this paper
• IMMUNOLOGY OF EXPERIMENTAL TUMORS.

  1964cited by this paper
• Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

  1960cited by this paper
• Immunity to methylcholanthrene-induced sarcomas.

  1957cited by this paper

• Cancer Neoantigen Vaccines Emerge Efficacious.

  2026cites this paper
• Approaches to overcome the current treatment plateau in immunotherapy.

  2025cites this paper
• Self-assembly of short peptides activates specific ER-phagy and induces pyroptosis for enhanced tumor immunotherapy.

  2025cites this paper
• Perspectives on the role of "-Omics" in predicting response to immunotherapy.

  2025cites this paper
• Cancer vaccines: Target antigens, vaccine platforms and preclinical models.

  2024cites this paper
• Neoantigen sequestrated autophagosomes as therapeutic Cancer vaccines.

  2024cites this paper
• Promising Nanomedicines of Shikonin for Cancer Therapy

  2023cites this paper
• Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies

  2023cites this paper
• External stimulation induces the secretion of autophagosome-like vesicles by B cells

  2023cites this paper
• Canonical and Non-Canonical Functions of the Autophagy Machinery in MHC Restricted Antigen Presentation

  2022cites this paper
• Amlexanox-modified platinum(IV) complex triggers apoptotic and autophagic bimodal death of cancer cells.

  2022cites this paper
• Autophagy and tumorigenesis

  2021cites this paper
• Non-canonical functions of autophagy proteins in immunity and infection.

  2021cites this paper
• Tumor-Derived Autophagosomes (DRibbles) Activate Human B Cells to Induce Efficient Antigen-Specific Human Memory T-Cell Responses

  2021cites this paper
• Enhancement of innate and adaptive anti-tumor immunity by serum obtained from vascular photodynamic therapy-cured BALB/c mouse

  2021cites this paper
• Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance.

  2021cites this paper
• Role of autophagy in antigen presentation and its involvement on cancer immunotherapy

  2020cites this paper
• Interplay between exosomes and autophagy: Are they partners in crime?

  2020cites this paper
• Emerging Autophagy Functions Shape the Tumor Microenvironment and Play a Role in Cancer Progression - Implications for Cancer Therapy

  2020cites this paper
• Involvement of autophagy in MHC class I antigen presentation

  2020cites this paper
• Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells

  2020cites this paper
• Double hit viral parasitism, polymicrobial CNS residency and perturbed proteostasis in Alzheimer's disease: A data driven, in silico analysis of gene expression data.

  2020cites this paper
• Cytoplasmic Cargo Receptor p62 Inhibits Avibirnavirus Replication by Mediating Autophagic Degradation of Viral Protein VP2

  2020cites this paper
• Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism

  2019cites this paper
• Association between p62 expression and clinicopathological characteristics in oral leukoplakia

  2019cites this paper
• Future Research Goals in Immunotherapy.

  2019cites this paper
• Immunotherapy for Head and Neck Cancer.

  2019cites this paper
• Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy.

  2019cites this paper
• The relationship between autophagy and the immune system and its applications for tumor immunotherapy

  2019cites this paper
• Immunotherapy for Head and Neck Cancer.

  2019cites this paper
• Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)

  2018cites this paper
• Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)

  2018cites this paper
• Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer

  2018cites this paper
• The long road: the autophagic network and TP53/ASXL1 aberrations in hematopoietic malignancies

  2018cites this paper
• Linking Autophagy and the Dysregulated NFκB/ SNAIL/YY1/RKIP/PTEN Loop in Cancer: Therapeutic Implications.

  2018cites this paper
• Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance

  2018cites this paper
• Inflammatory signaling cascades and autophagy in cancer

  2018cites this paper
• The multifaceted role of autophagy in cancer and the microenvironment

  2018cites this paper
• Coordinated IgG Antibody and CD8+ T Cell Recognition of Tumor Antigens

  2018influential citation
• Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination

  2018cites this paper
• Vx3-Functionalized Alumina Nanoparticles Assisted Enrichment of Ubiquitinated Proteins from Cancer Cells for Enhanced Cancer Immunotherapy.

  2018cites this paper
• Autophagy Proteins in Phagocyte Endocytosis and Exocytosis

  2017cites this paper
• Autophagy in the "inflammation-carcinogenesis" pathway of liver and HCC immunotherapy.

  2017cites this paper
• The Autophagic Machinery in Viral Exocytosis

  2017cites this paper
• Ubiquitinated Proteins Isolated From Tumor Cells Are Efficient Substrates for Antigen Cross-Presentation

  2017cites this paper
• A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

  2017cites this paper
• Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12–13 May 2017

  2017cites this paper
• The Macroautophagy Machinery in Endo- and Exocytosis.

  2017cites this paper
• Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression

  2016cites this paper
• TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles)

  2016cites this paper
• Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine

  2016cites this paper
• Microbial HSP70 peptide epitope 407–426 as adjuvant in tumor-derived autophagosome vaccine therapy of mouse lung cancer

  2016cites this paper
• Sorafenib and a novel immune therapy in lung metastasis from hepatocellular carcinoma following hepatectomy: A case report.

  2016cites this paper
• Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment: Proceedings of a Workshop

  2016cites this paper
• Future perspectives in melanoma research

  2016cites this paper
• Autophagy and Mammalian Viruses: Roles in Immune Response, Viral Replication, and Beyond.

  2016cites this paper
• Immunotherapy in Head and Neck Cancers

  2016cites this paper
• Tumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-κB signal pathway

  2016cites this paper
• Autophagy proteins in antigen processing for presentation on MHC molecules

  2016cites this paper
• Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy.

  2016cites this paper
• Autophagy Beyond Intracellular MHC Class II Antigen Presentation.

  2016cites this paper
• Coupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated Immunity

  2016cites this paper
• Ubiquitinated proteins enriched from tumor cells by a ubiquitin binding protein Vx3(A7) as a potent cancer vaccine

  2015cites this paper
• Immune responses of dendritic cells combined with tumor-derived autophagosome vaccine on hepatocellular carcinoma.

  2015cites this paper
• Of LAP, CUPS, and DRibbles – Unconventional Use of Autophagy Proteins for MHC Restricted Antigen Presentation

  2015cites this paper
• Therapeutic antitumor efficacy of tumor-derived autophagosome (DRibble) vaccine on head and neck cancer

  2015cites this paper
• Eradication of established murine mesothelioma tumours by combined immunotherapy

  2015cites this paper
• Autophagy as a Stress Response Pathway in the Immune System

  2015cites this paper
• RESULTS STING and IRF 3 Are Required for Spontaneous T Cell Activation against Tumors In Vivo

  2015cites this paper
• Developing an Immunotherapy Strategy for the Effective Treatment of Oral, Head and Neck Squamous Cell Carcinoma.

  2015cites this paper
• Trial watch

  2014cites this paper
• STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.

  2014cites this paper
• The STING pathway mediates innate immune sensing of immunogenic tumors

  2014cites this paper
• Therapeutic Antitumor Efficacy of B Cells Loaded With Tumor-derived Autophagasomes Vaccine (DRibbles)

  2014cites this paper
• Trial Watch

  2014cites this paper
• Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma

  2014cites this paper
• An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation

  2014influential citation
• Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells

  2014cites this paper
• Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors

  2014cites this paper
• The impact of macroautophagy on CD8+ T‐cell‐mediated antiviral immunity

  2013cites this paper
• Nanomaterials and Autophagy: New Insights in Cancer Treatment

  2013cites this paper
• Chloroquine engages the immune system to eradicate irradiated breast tumors in mice.

  2013cites this paper
• Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014

  2013cites this paper
• Autophagy and cellular immune responses.

  2013cites this paper
• Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”

  2013cites this paper
• Anti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine models.

  2013cites this paper
• Tumor-Derived Autophagosomes (DRibbles) Induce B Cell Activation in a TLR2-MyD88 Dependent Manner

  2013cites this paper
• Increasing the efficacy of tumor cell vaccines by enhancing cross priming.

  2012cites this paper
• Title Tumor-derived autophagosomes ( DRibbles ) induce B cellactivation in a TLR 2-MyD 88 dependent manner

  2012cites this paper
• Cross Priming in Active Immunotherapy : Activating Tumoricidal CD 8 T cells 2

  2012cites this paper
• The role of CD4[superscript +]T cells during adoptive and active-specific cancer immunotherapy

  2012cites this paper
• Autophagy-assisted antigen cross-presentation

  2012cites this paper
• Multiple vaccinations: friend or foe.

  2011cites this paper
• Cancer Therapy : Preclinical Tumor-Derived Autophagosome Vaccine : Mechanism of Cross-Presentation and Therapeutic Ef fi cacy

  2011cites this paper
• Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy

  2011cites this paper